The subtype GRPR is particularly relevant for the development of anticancer therapies and its overexpression has been reported in several cancer types such as small lung cell, head/neck squamous cell, colon, glioblastoma, breast and prostate cancer [3]. Here, GRPR is linked to prostate cancer.